Definitive Contract 75N92020C00029
Award Date
9/30/20
Potential Completion Date
9/29/23
Potential Value
$39M
Federal Agency
National Heart Lung and Blood Institute
Awardee
Luminostics Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95138, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $300,000 Small Business Innovation Research (SBIR) Phase I contract to Luminostics Inc., a for-profit organization, to develop a smartphone-based point-of-care test for the detection of influenza in low-resource settings. The contract has a completion date of August 18, 2020 and a potential value of $200,000. Luminostics Inc. is an experienced...
The National Institutes of Health's National Heart, Lung and Blood Institute awarded Lumiradx, Inc. a $243,000 firm fixed-price purchase order to finalize development of its SARS-CoV-2 and influenza A/B test. As the prime contractor, Lumiradx will deliver its LumiraDx Platform test to the NIH for use in detecting the viruses that cause COVID-19 and seasonal flu. No subcontractors or set-aside designations were identified. This purchase order supports the NIH's ongoing efforts to expand...
The Department of the Air Force Materiel Command awarded a $2 million firm fixed price definitive contract to Luminostics Inc. of Milpitas, California for its COVID-19 Rapid Antigen Test Kits Product Expansion Effort. The contract is for the delivery of COVID-19 rapid antigen test kits to support DOD testing requirements and will be performed in Milpitas through February 2022. Luminostics will provide the test kits as the prime contractor on this contract awarded through the Air Force's...
The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a firm fixed-price purchase order contract worth $5,389,813.00 to Luminex Corporation. The contract is for the integration of the SARS-CoV-2 virus with the NxTAG Respiratory Pathogen Panel and the submission of a 510(k) application to the U.S. Food and Drug Administration. Luminex is a manufacturer of biological testing technologies, including multiplex diagnostic solutions,...
This is a $5,240,000.00 firm fixed price definitive contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Lumiradx, Inc., a foreign-owned, for-profit organization. The contract is for Lumiradx to provide a SARS-CoV-2 & Flu A/B high sensitivity antigen assay under the RADX Tech program. The contract has an ultimate completion date of May 31, 2022 and was awarded on September 30, 2021. This contract is not associated with any set-aside designation.
Luminex Corporation was awarded a $642,450 firm fixed price definitive contract by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to develop an extended panel for the Luminex NXTAG COVID-19 diagnostic test. The contract is being performed in Austin, Texas over a period of four months ending July 1, 2020. This award was made under Special Instructions 019 of the department's Easy Broad Agency Announcement BAA-20-100-SOL-0002, which...
This is a $9,850,000.00 firm fixed price purchase order awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Luminex Corporation. The contract is to expand the use of Luminex's ARIES SARS-CoV-2 assay, which is a molecular diagnostic test for COVID-19. This award was not set aside for any specific business type. Luminex is a manufacturer of biological testing technologies, including multiplex diagnostic solutions,...
The Department of the Navy Bureau of Medicine and Surgery awarded a firm fixed price purchase order contract to Luminex Corp, a foreign-owned, for-profit manufacturer of biological testing technologies. The $84,171.36 contract is for the supply of 21 units of NxTAG Respiratory Pathogen Panel + SARS-CoV-2 (IVD-EUA) 96 Tests to be used in the Naval Health Research Center's laboratories in San Diego, California. The contract is not set aside for any special business category. Luminex will deliver...
This is a $96,195.84 firm fixed price purchase order awarded by the Department of the Navy's Bureau of Medicine and Surgery (BUMED) to Luminex Corp, a manufacturer of biological testing technologies, for the procurement of 24 units of the NxTAG Respiratory Pathogen Panel + SARS-CoV-2 test kits. The contract supports the Naval Health Research Center's (NHRC) laboratory testing requirements in San Diego, California. The award was made on a sole-source basis under the authority of 10 U.S.C....
Luminex Corporation was awarded a $132,000 firm fixed price contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 to provide COVID-19 testing supplies and equipment. The contract was awarded under the Multiple Award Schedule contracting vehicle to support the agency's response to the coronavirus pandemic. No set-aside provisions were applied to this award for COVID-19 related products and services. Performance will occur in...